Enlivex Therapeutics' Convertible Note - II Round

Enlivex Therapeutics raised a round of funding on May 19, 2014. Investors include Shai Novik.

Enlivex Therapeutics is an Israeli-based cell immunotherapy company developing an autologous and allogeneic drug pipeline for the treatment of autoimmune and inflammatory conditions such as Graft vers…

Articles about Enlivex Therapeutics' Convertible Note - II Round: